Navigation Links
Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition

hers obtained 13 blocks of paraffin-embedded tissue samples from seven NSF/NFD patients exposed to gadolinium from the national NSF Registry of New Haven, Conn.1. An additional paraffin-embedded block containing tissue from a routine dermatopathology case served as the negative control. Researchers used a field emission scanning electron microscope equipped with electron dispersion spectroscopy to search the tissue for metals. They also were blinded as to which blocks of tissue were from NSF/NFD cases and which were from negative controls.

The study found that gadolinium was detected in four of 13 tissue specimens from patients with NSF/NFD who were exposed to the contrast agent. As expected, none of the negative controls tested positive for gadolinium.

“While clearly more research needs to be done, we are encouraged by our findings and hope that it provides an important first step in understanding the cause of this elusive disease,” said Dr. High. “Until more data becomes available, we urge patients with end-stage kidney disease and their health care providers to be aware of this potentially fatal association between gadolinium and NSF/NDF and make every effort to avoid any unnecessary, excessive dosage of this contrast agent.”

Source-Newswie
SRM
'"/>




Page: 1 2

Related medicine news :

1. Chances of Survival for Melanoma is High When Detected by Dermatologists
2. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
3. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
4. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
5. Leeches Provide Clues Regarding The Prevention Of Heart Disease
6. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
7. Reindeer Provide Valuable Insights Into Sleep Disorders
8. London Hospital Provides Specialized Care For Pregnant Women
9. CNIC To Provide Funds To Mount Sinai School
10. Clean Blades To Be Provided To Self-Harmers
11. Breastfeeding Provides Added Protection To Babies

Post Your Comments:
(Date:11/8/2009)...s House Passage of Health Care Reform Bill ,, ...mprove coverage for all Americans ,, CHICAGO, ...d States House of Representatives passed by a vote...on that would strengthen Medicare for seniors and ...ces millions of Americans out of affordable health...
(Date:11/7/2009)...Nov. 7 Karen Ignagni, P...ns (AHIP), released the following statement today ... strongly support comprehensive health care reform...oposing a complete overhaul of how health insuranc...anteed coverage, elimination of pre-existing condi...
(Date:11/7/2009).... Coleman (CT), David A. Cook (GA), Louis J. Goodm...) Honored ,, CHICAGO, Nov. 7 /PRNewswire-USNew...oday presented five medical society executive lead...utions to the goals and ideals of the medical prof...i-annual policy making meeting in Houston. ,, ...
(Date:11/7/2009)...ithful Catholics have a responsibility to vigorous...e status quo." ,, WASHINGTON, Nov. 7 /PRNew...nt Judie Brown released the following statement on... Speaker Nancy Pelosi,s Affordable Health Care for...eserving the status quo for abortion is voted upon...
(Date:11/7/2009)... The Public Relations Society of America (PRSA) wi...ne Gage Lofgren, senior vice president of Brand St...e, tonight at a ceremony at PRSA,s 2009 Internatio...into the PRSA College of Fellows is one of the pro... Herman, APR, SAGE, Fellow PRSA, and 2009 chair of...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3
...will benefit, SACRAMENTO, Calif., Oct. 10 The go... State University (CSU) retirees to,participate in... "We are very grateful that the Legislature and go...n people have good,vision care, they have a greate...
...y Health System (VHS),caregivers, members of SEIU ...whelmingly last week to endorse Measure G on the N...uled for Thursday, October 11th, 12:00pm, at,the s...t Valley Medical Center, Menifee Valley Medical Ce...
... Access to Affordable Health Insurance, ERIE, Pa....nians, the centerpiece of his "Prescription for Pe...vernor Edward G. Rendell today held a,town meeting...e. Erie County has more than 10,000 uninsured adul...
... in the U.S. may,be breathing its last gasps, with...n America Act this past week. It now moves on to t...cted to be imminent. Championed by,Senator Patty M...ng in developing effective treatment for Mesotheli...
...onal Medical,Association (NMA) announced the appoi...ternal Affairs., "Alisa has done a terrific job a...d members of the Board of Trustees along with me a...the Director of External Affairs, Ms. Mosley will ...
...ty with breast cancer who are given drugs in addit...vant chemotherapy, may not be benefiting from thes...espond to changing levels of hormones such as estr...erms of survival," explained lead researcher Dr J ...
Other Medicine News:Health News:Governor Signs Bill Providing Vision Care Program for State University Retirees 2Health News:Valley Health System Caregivers, Members of SEIU UHW, to Announce Endorsement of Measure G 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 2Health News:Governor Rendell Launches 'Tour to Insure' In Erie; 3Health News:A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban 2Health News:A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban 3Health News:Cancer conflict with chemotherapy treatment 2
(Date:11/6/2009)...Nov. 6 GeoVax Labs, Inc...mpany"), an Atlanta-based, biopharmaceutical compa...y HIV-1 (Human Immunodeficiency Virus) and other i...r 2009 financial results and provided an operation...and Chief Executive Officer commented, "We are ple...
(Date:11/6/2009)..., November 6 , - Trial Wi...d for the,Treatment of Multi-Resistant Staphylococ... speciality pharmaceutical company focused on the ...igned to overcome the significant global,problem o...ost advanced oral,antibacterial NXL103 (flopristin...
(Date:11/5/2009)...ntario, Nov. 5 Helix Bio...unced today that its Phase II trial of Topical Int...warts (AGW) has completed patient enrollment, with...e trial. ,, The double-blind and placebo-contro...s in Germany and Sweden. Patients participating i...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Nanoparticle delivered 26apos 3BSuicide 26apos 3B Genes Slowed Ovarian Tumor Growth 53171 1Nanoparticle delivered 26apos 3BSuicide 26apos 3B Genes Slowed Ovarian Tumor Growth 53171 2Nanoparticle delivered 26apos 3BSuicide 26apos 3B Genes Slowed Ovarian Tumor Growth 53171 3First genetically engineered malaria vaccine to enter human trials 13267 1First genetically engineered malaria vaccine to enter human trials 13267 2U S Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International 13265 1U S Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International 13265 2U S Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International 13265 3U S Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International 13265 4
Active Ankle Orthosis(Trainers)
Bledsoe M-Brace Ankle Support
Bledsoe Short Term Boot
Bledsoe Low Cost Boot
Medicine Products: